Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:DRTS NASDAQ:LUNG NASDAQ:NYXH NASDAQ:TCMD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDRTSAlpha Tau Medical$3.39+3.7%$3.06$2.06▼$4.39$277.36M0.9946,499 shs96,722 shsLUNGPulmonx$1.55-4.3%$2.76$1.54▼$9.37$66.01M0.43965,464 shs788,604 shsNYXHNyxoah$7.42-1.1%$7.68$5.55▼$11.87$255.45M1.6149,357 shs210,927 shsTCMDTactile Systems Technology$12.28-1.3%$10.26$8.61▼$21.10$277.31M0.96250,764 shs225,255 shs7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDRTSAlpha Tau Medical+3.67%+13.76%+3.99%+16.10%+65.37%LUNGPulmonx-4.32%-3.73%-43.22%-54.28%-73.55%NYXHNyxoah-1.07%+1.64%-4.26%+17.78%-9.95%TCMDTactile Systems Technology-1.29%+27.25%+21.22%+28.99%-8.83%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationDRTSAlpha Tau Medical2.4246 of 5 stars3.53.00.00.02.71.70.0LUNGPulmonx3.8148 of 5 stars4.33.00.00.02.03.31.3NYXHNyxoah2.5905 of 5 stars3.54.00.00.00.00.80.6TCMDTactile Systems Technology2.1926 of 5 stars1.21.00.00.03.82.53.1Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDRTSAlpha Tau Medical 3.00Buy$8.00135.99% UpsideLUNGPulmonx 2.56Moderate Buy$7.66394.47% UpsideNYXHNyxoah 3.00Buy$15.00102.16% UpsideTCMDTactile Systems Technology 2.40Hold$13.509.93% UpsideCurrent Analyst Ratings BreakdownLatest LUNG, DRTS, NYXH, and TCMD Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/5/2025TCMDTactile Systems TechnologyWilliam BlairSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy8/5/2025TCMDTactile Systems TechnologyB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral$12.00 ➝ $13.008/1/2025LUNGPulmonxWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$6.00 ➝ $3.007/31/2025LUNGPulmonxLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$12.00 ➝ $8.007/31/2025LUNGPulmonxStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$16.00 ➝ $5.007/31/2025LUNGPulmonxD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$17.00 ➝ $16.007/31/2025LUNGPulmonxPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeOverweight ➝ Neutral$9.00 ➝ $2.505/22/2025LUNGPulmonxCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$6.50 ➝ $4.15(Data available from 8/9/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDRTSAlpha Tau MedicalN/AN/AN/AN/A$0.89 per shareN/ALUNGPulmonx$83.79M0.75N/AN/A$1.70 per share0.91NYXHNyxoah$4.89M51.68N/AN/A$3.60 per share2.06TCMDTactile Systems Technology$292.98M0.93$1.07 per share11.49$8.74 per share1.41Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDRTSAlpha Tau Medical-$31.75M-$0.46N/AN/AN/AN/A-49.48%-36.69%8/13/2025 (Estimated)LUNGPulmonx-$56.39M-$1.43N/AN/AN/A-62.88%-69.76%-36.26%N/ANYXHNyxoah-$64.10M-$2.13N/AN/AN/A-1,571.39%-63.37%-46.67%8/18/2025 (Estimated)TCMDTactile Systems Technology$16.96M$0.6219.8114.62N/A5.06%7.72%5.59%N/ALatest LUNG, DRTS, NYXH, and TCMD EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/18/2025Q2 2025NYXHNyxoah-$0.60N/AN/AN/A$1.33 millionN/A8/13/2025Q2 2025DRTSAlpha Tau Medical-$0.12N/AN/AN/AN/AN/A8/4/2025Q2 2025TCMDTactile Systems Technology$0.09$0.14+$0.05$0.14$73.93 million$78.91 million7/30/2025Q2 2025LUNGPulmonx-$0.40-$0.38+$0.02-$0.38$23.46 million$23.86 million5/19/2025Q1 2025DRTSAlpha Tau Medical-$0.14-$0.12+$0.02-$0.12$0.03 millionN/A5/14/2025Q1 2025NYXHNyxoah-$0.49-$0.63-$0.14-$0.63$1.64 million$1.12 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDRTSAlpha Tau MedicalN/AN/AN/AN/AN/ALUNGPulmonxN/AN/AN/AN/AN/ANYXHNyxoahN/AN/AN/AN/AN/ATCMDTactile Systems TechnologyN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDRTSAlpha Tau Medical0.105.815.81LUNGPulmonx0.545.354.29NYXHNyxoah0.223.593.35TCMDTactile Systems Technology0.113.793.99Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDRTSAlpha Tau Medical2.65%LUNGPulmonx91.04%NYXHNyxoahN/ATCMDTactile Systems Technology83.43%Insider OwnershipCompanyInsider OwnershipDRTSAlpha Tau Medical39.50%LUNGPulmonx6.80%NYXHNyxoah17.11%TCMDTactile Systems Technology2.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDRTSAlpha Tau Medical8084.82 million51.32 millionNo DataLUNGPulmonx25040.75 million37.98 millionOptionableNYXHNyxoah11034.06 million28.23 millionNot OptionableTCMDTactile Systems Technology1,03722.29 million21.74 millionOptionableLUNG, DRTS, NYXH, and TCMD HeadlinesRecent News About These CompaniesWhat is B. Riley's Estimate for TCMD Q1 Earnings?August 8 at 9:36 AM | marketbeat.comQ3 Earnings Forecast for TCMD Issued By William BlairAugust 8 at 8:02 AM | marketbeat.comEquities Analysts Issue Forecasts for TCMD Q1 EarningsAugust 8 at 4:05 AM | americanbankingnews.comWhat is B. Riley's Forecast for TCMD Q3 Earnings?August 8 at 2:09 AM | americanbankingnews.comTactile Systems Technology, Inc. (NASDAQ:TCMD) Receives Consensus Recommendation of "Hold" from AnalystsAugust 7 at 7:12 AM | marketbeat.comWilliam Blair Upgrades Tactile Systems Technology (NASDAQ:TCMD) to Strong-BuyAugust 7 at 6:59 AM | marketbeat.comB. Riley Analysts Reduce Earnings Estimates for TCMDAugust 7 at 6:46 AM | marketbeat.comTactile Systems Technology, Inc. (NASDAQ:TCMD) Q2 2025 Earnings Call TranscriptAugust 7 at 3:02 AM | msn.comTactile Systems Technology (NASDAQ:TCMD) Earns "Neutral" Rating from B. RileyAugust 7 at 2:15 AM | americanbankingnews.comB. Riley Issues Positive Forecast for Tactile Systems Technology (NASDAQ:TCMD) Stock PriceAugust 6 at 11:52 AM | marketbeat.comIs Tactile Systems Technology (TCMD) Stock Undervalued Right Now?August 6 at 10:40 AM | zacks.comTactile Systems Technology (TCMD) Just Overtook the 20-Day Moving AverageAugust 6 at 10:36 AM | zacks.comTactile Systems Technology (TCMD) Recently Broke Out Above the 50-Day Moving AverageAugust 6 at 10:31 AM | zacks.comTactile Systems outlines 2025 revenue guidance of $310M-$315M while strengthening airway clearance growthAugust 6 at 4:16 AM | msn.comTactile Systems Technology (NASDAQ:TCMD) Posts Quarterly Earnings Results, Beats Expectations By $0.05 EPSAugust 5, 2025 | marketbeat.comTactile Systems Technology, Inc. (TCMD) Q2 2025 Earnings Call TranscriptAugust 4, 2025 | seekingalpha.comTactile Systems Technology (TCMD) Surpasses Q2 Earnings and Revenue EstimatesAugust 4, 2025 | zacks.comTactile Systems (TCMD) Q2 Revenue Up 8%August 4, 2025 | fool.comTactile Systems Technology, Inc. Reports Second Quarter 2025 Financial ResultsAugust 4, 2025 | globenewswire.comTactile Systems Technology, Inc. (NASDAQ:TCMD) Holdings Decreased by Federated Hermes Inc.August 4, 2025 | marketbeat.comVictory Capital Management Inc. Invests $1.16 Million in Tactile Systems Technology, Inc. (NASDAQ:TCMD)July 31, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Short Squeeze Candidates With Big Catalysts on the HorizonBy Dan Schmidt | July 25, 2025View 3 Short Squeeze Candidates With Big Catalysts on the HorizonWhy the American Eagle Stock Rally Isn't Just Speculation By Gabriel Osorio-Mazilli | July 28, 2025View Why the American Eagle Stock Rally Isn't Just Speculation America Wants Drone Dominance: Are These Stocks Ready to Soar?By Chris Markoch | July 20, 2025View America Wants Drone Dominance: Are These Stocks Ready to Soar?Super Micro Computer Sees Unusual Volume—Catalyst Ahead?By Gabriel Osorio-Mazilli | July 25, 2025View Super Micro Computer Sees Unusual Volume—Catalyst Ahead?Spotify's Q2 Earnings Plunge: An Opportunity or Ominous Signal?By Leo Miller | July 31, 2025View Spotify's Q2 Earnings Plunge: An Opportunity or Ominous Signal?LUNG, DRTS, NYXH, and TCMD Company DescriptionsAlpha Tau Medical NASDAQ:DRTS$3.39 +0.12 (+3.67%) Closing price 08/8/2025 03:59 PM EasternExtended Trading$3.31 -0.08 (-2.36%) As of 08/8/2025 06:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, prostate, and breast cancers; and preclinical studies for brain, hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.Pulmonx NASDAQ:LUNG$1.55 -0.07 (-4.32%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$1.55 0.00 (0.00%) As of 08/8/2025 07:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Pulmonx Corporation, a commercial-stage medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. The company offers Zephyr Endobronchial Valve, a solution for the treatment of patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. It also offers StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. The company serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.Nyxoah NASDAQ:NYXH$7.42 -0.08 (-1.07%) Closing price 08/8/2025 03:59 PM EasternExtended Trading$7.85 +0.43 (+5.80%) As of 08/8/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.Tactile Systems Technology NASDAQ:TCMD$12.28 -0.16 (-1.29%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$12.14 -0.14 (-1.13%) As of 08/8/2025 06:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Airbnb Beats Earnings, But the Growth Story Is Losing Altitude Dutch Bros Just Flipped the Script With a Massive Earnings Beat Amazon Takes an Equity Stake in IonQ—Any Upside Potential? D-Wave Delivers Growth Shock—Investors Eye Quantum Future Is Eli Lilly’s 14% Post-Earnings Slide a Buy-the-Dip Opportunity? Constellation Energy’s Earnings Beat Signals a New Era AppLovin’s Q2 Miss Spooks Market, But Wall Street Doubles Down DraftKings Posts Record Quarter, Eyes Profitability Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
